Literature DB >> 16930253

Editorial: drug development for neglected diseases: a public health challenge.

Angela Fehr, Petra Thürmann, Oliver Razum.   

Abstract

Mesh：

Year:  2006        PMID： 16930253     DOI： 10.1111/j.1365-3156.2006.01714.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN： 1360-2276            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Development of and access to products for neglected diseases.

Authors:  Joshua Cohen; Maria Staroselsky Dibner; Andrew Wilson
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

2.  [Documentation of outpatient treatment of Paget's disease in Westphalia-Lippe. Descriptive analysis of statutory health insurance data for the year 2005].

Authors:  T Altenhöner; E Dorendorf; O Razum; M Hertrich; C Bonnemann
Journal:  Z Rheumatol       Date:  2009-09       Impact factor: 1.372

3.  Expert Delphi survey on research and development into drugs for neglected diseases.

Authors:  Angela Fehr; Petra Thürmann; Oliver Razum
Journal:  BMC Health Serv Res       Date:  2011-11-16       Impact factor: 2.655

4.  The German government's global health strategy--a strategy also to support research and development for neglected diseases?

Authors:  Angela Fehr; Oliver Razum
Journal:  Glob Health Action       Date:  2014-07-28       Impact factor: 2.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.